SELICK HAROLD E has filed 14 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 24000 shares of Protagonist Therapeutics, Inc ($PTGX) on March 26, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | M | Common Stock | 24000 | $12.88 | 84,845.0000 | 63,573,048 | 39.44% | 0.04% |
| March 26, 2026 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | M | Stock Option (right to buy) | 24000 | $0.00 | 0.0000 | 63,573,048 | 100.00% | 0.04% |
| March 26, 2026 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | S | Common Stock | 24000 | $105.00 | 60,845.0000 | 63,573,048 | 28.29% | 0.04% |
| Jan. 9, 2026 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | M | Stock Option (right to buy) | 14299 | $0.00 | 0.0000 | 63,573,048 | 100.00% | 0.02% |
| Jan. 9, 2026 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | M | Common Stock | 14299 | $4.21 | 60,845.0000 | 63,573,048 | 30.72% | 0.02% |
| Jan. 2, 2026 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | A | Stock Option (right to buy) | 3762 | $0.00 | 3,762.0000 | 63,573,048 | 9999.99% | 0.01% |
| Jan. 2, 2026 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | A | Common Stock | 2695 | $0.00 | 46,546.0000 | 63,573,048 | 6.15% | 0.00% |
| April 28, 2025 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | M | Common Stock | 10725 | $1.16 | 43,851.0000 | 62,963,806 | 32.38% | 0.02% |
| April 28, 2025 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | M | Stock Option (right to buy) | 10725 | $0.00 | 0.0000 | 62,963,806 | 100.00% | 0.02% |
| Jan. 2, 2025 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | A | Stock Option (right to buy) | 6584 | $0.00 | 6,584.0000 | 65,077,722 | 9999.99% | 0.01% |
| Jan. 2, 2025 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | A | Common Stock | 5130 | $0.00 | 33,126.0000 | 65,077,722 | 18.32% | 0.01% |
| March 7, 2024 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | M | Common Stock | 6490 | $1.89 | 27,996.0000 | 56,763,559 | 30.18% | 0.01% |
| March 7, 2024 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | M | Stock Option (right to buy) | 6490 | $0.00 | 0.0000 | 56,763,559 | 100.00% | 0.01% |
| Jan. 2, 2024 | Protagonist Therapeutics, Inc | $PTGX | SELICK HAROLD E | Director | A | Stock Option (right to buy) | 25700 | $0.00 | 25,700.0000 | 56,763,559 | 9999.99% | 0.05% |